Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HYBRID TYPE COMPOUND OR SALT THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/238919
Kind Code:
A1
Abstract:
Provided is an anticancer agent capable of efficaciously acting on a Ras mutated cancer. The present invention provides a hybrid type compound, in which trametinib is linked to an Akt inhibitor via a linker, or a salt thereof.

Inventors:
WATANABE YOSHIHIRO (JP)
KUNISHIMA MUNETAKA (JP)
FUJITA HIKARU (JP)
YANO SEIJI (JP)
ARAI SACHIKO (JP)
TAMAI IKUMI (JP)
ARAKAWA HIROSHI (JP)
INOKUMA YASUHIDE (JP)
Application Number:
PCT/JP2023/021442
Publication Date:
December 14, 2023
Filing Date:
June 09, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
WATANABE YOSHIHIRO (JP)
International Classes:
A61K47/55; A61K31/519; A61P35/00; C07D471/04; C07D519/00
Foreign References:
JP2019519593A2019-07-11
Other References:
YOSHIDA TAKAYUKI, KAKEGAWA JUNYA, YAMAGUCHI TAKAYUKI, HANTANI YOSHIJI, OKAJIMA NOBUYUKI, SAKAI TOSHIYUKI, WATANABE YOSHIHIRO, NAKA: "Identification and Characterization of a Novel Chemotype MEK Inhibitor Able to Alter the Phosphorylation State of MEK1/2", ONCOTARGET, IMPACT JOURNALS LLC, UNITED STATES, vol. 3, no. 12, 31 December 2012 (2012-12-31), United States , pages 1533 - 1545, XP093114742, ISSN: 1949-2553, DOI: 10.18632/oncotarget.747
WU Y. LINDA, MAACHANI UDAY BHANU, SCHWEITZER MELANIE, SINGH RANJODH, WANG MELINDA, CHANG RAYMOND, SOUWEIDANE MARK M.: "Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells", TRANSLATIONAL ONCOLOGY, NEOPLASIA PRESS, UNITED STATES, vol. 10, no. 2, 1 April 2017 (2017-04-01), United States , pages 221 - 228, XP093114743, ISSN: 1936-5233, DOI: 10.1016/j.tranon.2016.12.008
Attorney, Agent or Firm:
HIRAKI & ASSOCIATES (JP)
Download PDF: